Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort study

  • 0Department of Psychosocial Rehabilitation, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan. saita@hiroshima-u.ac.jp.

|

|

Summary

This summary is machine-generated.

Gastrointestinal cancer survivors undergoing chemotherapy may experience memory deficits. Functional near-infrared spectroscopy (fNIRS) is a feasible tool for monitoring brain activity and understanding cancer-related cognitive impairment (CRCI).

Area Of Science

  • Neuroscience
  • Oncology
  • Cognitive Psychology

Background

  • Cancer-related cognitive impairment (CRCI) presents diverse risk factors.
  • Neuroimaging is recommended to complement subjective and objective cognitive assessments.
  • Evaluating CRCI in gastrointestinal cancer survivors requires robust assessment protocols.

Purpose Of The Study

  • To assess the feasibility of a multidomain assessment protocol for CRCI in gastrointestinal cancer survivors.
  • To investigate cognitive function and cerebral hemodynamics in chemotherapy patients.
  • To establish a baseline for future CRCI research in cancer survivors.

Main Methods

  • 24 gastrointestinal cancer patients and 24 healthy controls were recruited.
  • Cognitive function was assessed using FACT-Cog, Trail Making Test, AVLT, and verbal fluency.
  • Cerebral hemodynamic changes in the prefrontal cortex were measured using portable functional near-infrared spectroscopy (P-NIRS).

Main Results

  • A significant difference in auditory verbal learning test (AVLT)-delayed recall was observed in the chemotherapy group compared to controls (p=0.002).
  • The chemotherapy group showed reduced left frontal pole activity at 6 months post-treatment (p=0.018).
  • No significant differences were found in other cognitive assessments between groups.

Conclusions

  • Gastrointestinal cancer survivors receiving chemotherapy may have impaired memory recall.
  • P-NIRS monitoring of prefrontal cortex hemodynamics is feasible for clinical application in CRCI.
  • Multidomain assessments are translatable to clinical practice and beneficial for understanding CRCI impacts.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28

147

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: 5-HT<sub>3</sub> Receptor Antagonists 01:27

173

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Cancer Therapies 02:49

7.5K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids 01:21

199

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Cognitive Development During Adulthood 01:30

45

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Assessment of the Gastrointestinal System I: Subjective Data 01:17

131

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...